Association between metformin use and reduced short- and long-term all-cause mortality in patients undergoing cardiac surgery: a retrospective cohort study

被引:0
作者
Chen, Bin [1 ]
Tai, Yanghao [1 ]
Kong, Yingming [1 ]
Wang, Chunyan [2 ]
机构
[1] Shanxi Med Univ, Shanxi Acad Med Sci, Shanxi Bethune Hosp, Tongji Shanxi Hosp,Hosp 3, Taiyuan 030032, Peoples R China
[2] Shanxi Med Univ, Chinese Acad Med Sci, Shanxi Prov Canc Hosp, Shanxi Hosp,Canc Hosp,Dept Med Lab, Taiyuan, Peoples R China
关键词
Cardiac surgery; Perioperative period; Metformin; Intensive care unit; Mortality; Diabetes; ACUTE KIDNEY INJURY; BYPASS GRAFT-SURGERY; OXIDATIVE STRESS; RISK; HEART; OUTCOMES;
D O I
10.1186/s40001-025-02878-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aims The use of metformin during the perioperative period remains a contentious issue. This study aimed to assess the impact of metformin use on overall mortality rates among patients in postoperative cardiac intensive care units. Materials and methods This study retrospectively analyzed data from 8675 cardiac surgery patients sourced from the Medical Information Marketplace in Intensive Care (MIMIC 3.0) database. The administration of metformin during the postoperative ICU stay was assessed. Utilizing Cox proportional hazards modeling, the study explored the correlation between metformin treatment and all-cause mortality (ACM). The impact of metformin on survival rates was examined using the Kaplan-Meier method. Subgroup analyses and interaction tests were conducted to ascertain the consistency of these associations across diverse demographic and clinical subgroups. Results The average age of participants in this study was 69.0 years, spanning from 61.0 to 76.0 years. A higher proportion of individuals who received metformin following surgery were male (75.6% vs 72.3%, P = 0.01), younger (67.19 +/- 9.26 vs 67.95 +/- 11.75, P = 0.006), and had lower Sequential Organ Failure Assessment Scores (4.92 +/- 2.38 vs 5.31 +/- 2.79, P < 0.001). When compared with patients who did not receive metformin after surgery, these individuals who received metformin following surgery had a lower prevalence of chronic kidney disease, congestive heart failure, and peripheral vascular disease and the higher prevalence of acute myocardial infarction, hypertension and diabetes. The metformin administration was correlated to decreased ACM at 28, 60, 90, and 365 days. Conclusions Utilizing metformin in the intensive care unit following surgery was correlated with the notable reduction in ACM among patients who have undergone cardiac procedures, particularly those with diabetes. However, further prospective research is necessary to validate these findings.
引用
收藏
页数:9
相关论文
共 42 条
[1]   Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study [J].
Andersson, C. ;
Olesen, J. B. ;
Hansen, P. R. ;
Weeke, P. ;
Norgaard, M. L. ;
Jorgensen, C. H. ;
Lange, T. ;
Abildstrom, S. Z. ;
Schramm, T. K. ;
Vaag, A. ;
Kober, L. ;
Torp-Pedersen, C. ;
Gislason, G. H. .
DIABETOLOGIA, 2010, 53 (12) :2546-2553
[2]   Stroke after Cardiac Surgery: A Risk Factor Analysis of 580,117 Patients from UK National Adult Cardiac Surgical Audit Cohort [J].
Asta, Laura ;
Falco, Daniele ;
Benedetto, Umberto ;
Porreca, Annamaria ;
Majri, Fatma ;
Angelini, Gianni D. ;
Sensi, Stefano ;
Di Giammarco, Gabriele .
JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (02)
[3]   Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications [J].
Bashraheel, Sara S. ;
Kheraldine, Hadeel ;
Khalaf, Sarah ;
Al Moustafa, Ala-Eddin .
BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
[4]   Metformin therapy and postoperative atrial fibrillation in diabetic patients after cardiac surgery [J].
Basnet, Suresh ;
Kozikowski, Andrzej ;
Sun, Haiyan ;
Troup, Melissa ;
Urrutia, Luis E. ;
Pekmezaris, Renee .
JOURNAL OF INTENSIVE CARE, 2017, 5
[5]   The intersection of metformin and inflammation [J].
Bharath, Leena P. ;
Nikolajczyk, Barbara S. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 320 (05) :C873-C879
[6]   Acute Kidney Injury after Cardiac Surgery: Prediction, Prevention, and Management [J].
Cheruku, Sreekanth R. ;
Raphael, Jacob ;
Neyra, Javier A. ;
Fox, Amanda A. .
ANESTHESIOLOGY, 2023, 139 (06) :880-898
[7]   Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis [J].
Coyle, C. ;
Cafferty, F. H. ;
Vale, C. ;
Langley, R. E. .
ANNALS OF ONCOLOGY, 2016, 27 (12) :2184-2195
[8]   Complications After Cardiac Operations: All Are Not Created Equal [J].
Crawford, Todd C. ;
Magruder, J. Trent ;
Grimm, Joshua C. ;
Suarez-Pierre, Alejandro ;
Sciortino, Christopher M. ;
Mandal, Kaushik ;
Zehr, Kenton J. ;
Conte, John V. ;
Higgins, Robert S. ;
Cameron, Duke E. ;
Whitman, Glenn J. .
ANNALS OF THORACIC SURGERY, 2017, 103 (01) :32-40
[9]   The role of AMPK in macrophage metabolism, function and polarisation [J].
Cui, Yinxing ;
Chen, Junhua ;
Zhang, Zhao ;
Shi, Houyin ;
Sun, Weichao ;
Yi, Qian .
JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
[10]   Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial [J].
El Messaoudi, Saloua ;
Nederlof, Rianne ;
Zuurbier, Coert J. ;
van Swieten, Henry A. ;
Pickkers, Peter ;
Noyez, Luc ;
Dieker, Hendrik-Jan ;
Coenen, Marieke J. ;
Donders, A. Rogier T. ;
Vos, Annemieke ;
Rongen, Gerard A. ;
Riksen, Niels P. .
LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (08) :615-623